The time course of the relative myocardial phosphocreatine and adenosine triphosphate contents (PCr/ATP) during step changes in heart rate in vivo was studied in 14 dogs using 31P nuclear magnetic resonance (NMR) 
Introduction
Adenosine triphosphate (ATP) is the major intermediary between the metabolic energy conversion processes (i.e., glycolysis and oxidative phosphorylation) and the contractile elements (i.e., myofibrils) in the heart. As such, the variations in the high energy phosphate compounds have been used as an index of the balance between myocardial energy consumption and supply. With the recent application of 31P nuclear magnetic resonance (NMR)' techniques it is now feasible to follow the concentrations in vivo of these important intermediates of energy metabolism (1) .
Previous studies using 31P NMR have provided valuable information on the metabolic effects of myocardial hypoxia, ischemia, and work (2) (3) (4) . One (5, 6) . This observation was particularly surprising considering the widely held view that the rate of mitochondrial oxidative phosphorylation is modulated by variations in the concentrations ofthe ATP hydrolysis products, namely inorganic phosphorus (Pi) and ADP (7, 8) . (9) . Previous 31p NMR studies have either intentionally focused on periods of stable myocardial metabolism or have lacked sufficient time resolution to detect these predicted transient changes.
The purpose of this study was to use time-resolved 31p NMR spectroscopy (resolution 15-16 s) to determine whether or not transient changes occur in myocardial phosphocreatine (PCr) and ATP over the course of rapid changes in cardiac work. This information is important in determining the mechanism of mitochondrial respiratory control during an increase in cardiac work. The time course of these measurements is compared to the simultaneously occurring changes in left ventricular blood flow and arterial blood pressure for workloads both within and exceeding the hemodynamic reserves of the heart. These studies also were conducted to evaluate the time course of the phosphate metabolite response to the supply/demand mismatch that occurs with high levels of artificially induced tachycardia.
Methods
Surgical preparation. 14 beagles of either sex (body weight [10] [11] [12] [13] [14] [15] [16] kg) were sedated with 20 mg/kg thiopental i.v., intubated and ventilated using a servo-pediatric ventilator (900D; Siemens-Elema AB, Solna, Sweden). The gas mixture consisted of 80% 02, 0.7-1.0% halothane to maintain anesthesia and N20 balance. Respiratory rate was set at -0.5 Hz and changes in minute volume, when indicated by arterial blood gas measurements, were made by varying the tidal volume. Aortic pressure and arterial blood gases were measured from a cannula advanced into the aorta via the left carotid artery. The cannula was connected to a solid state, nonmagnetic transducer (Cobe Laboratories, Inc., Lakewood, CO) located immediately outside of the magnet. A median sternotomy was performed and all pericardial fat was removed by blunt dissection and low current cautery.
In nine dogs, heparin (initial dose 2000 U) was administered intravenously. The ends of a shunt ofTygon tubing (1/8 inch i.d., 1/4 inch o.d. length 35 cm; Norton Performance Plastics, Akron, OH) were passed from the left jugular vein into the coronary sinus and from the right jugular vein into the right atrium. A suture (3-0 Tevdek II, noncutting needle; Pfizer Hospital Group, Inc., Queens Village, NY) was placed around the coronary sinus near its junction with the right atrium and tied over the tubing. Thus, coronary sinus blood flow was diverted through the extracorporeal shunt and returned to the right atrium. The shunt contained a flow probe (Transonics Systems Inc., Ithaca, NY) and a port for sampling the coronary sinus blood (10) . Hydration was maintained with Ringer's solution given through a peripheral venous cannula. Bipolar pacing leads were placed on the surface of the right atrium through a small incision in the pericardium. A two-turn, home-built surface coil (3 cm o.d.) was sutured to the pericardium overlying the anteroseptal portion of the left ventricle as previously described (I 1). The animals were then placed on a circulating warm water blanket in a rigid plastic cradle that permitted centering of the heart in the x-y axes. The thoracotomy was sealed with plastic wrap to reduce heat and water loss and the entire preparation was wrapped in a heat reflective "space blanket" (Boy Scouts of America, Charlotte, NC). In previous studies, we have found that this technique maintained the animals body temperature at 37±0.50C (11) . The animal and cradle were moved into the NMR magnet without interrupting the positive pressure ventilation and positioned to center the heart along the z axis of the magnetic field. The remaining five dogs were not heparinized and a coronary sinus shunt was not placed, but otherwise underwent the same protocol as the animals with shunts. Hardcopies of blood pressure, heart rate, and coronary sinus flow were made on a Gould 2600S recorder (Gould, Inc., Cleveland, OH), along with a digital pulse from the NMR spectrometer to verify the timing of data acquisitions relative to the cardiac cycle. All protocols were approved by the Intramural NHLBI Animal Care and Use Committee (protocol 6-KE-1).
NMR measurements. All experiments were conducted in a 4.7 Tesla 26 cm horizontal clear bore magnet (Oxford Instruments, Oxford, UK) equipped with a CSI spectrometer (General Electric Corp., Freemont, CA). The surface coil was tuned to 81 MHz and matched to 50 ohms. All pulse sequences were triggered from the ventilator digital pulse at the start of inspiration. The heart was paced at a precise harmonic ofthe respiratory rate synchronized to the ventilator using a laboratory computer (Digital MINC 1 1/73) (1 1). Although it has been previously demonstrated that the high energy phosphate compounds do not change significantly over the time course of the cardiac cycle (12, 13) , NMR data acquisitions at all heart rates were timed to occur during the first diastole at the beginning of a respiratory cycle to minimize motion artifacts. The field was manually shimmed using the proton free induction decay (FID) at 200 MHz ('H linewidth 36-48 Hz). 31p spectra were collected using a simple one pulse and collect method with a pulse width of40-50 ,s and an interpulse delay of -2 s (determined by the precise respiratory rate). This pulse width choosen in each animal as providing the maximum PCr signal to noise for the interpulse delay used (1 1). Before and after the experimental protocol, reference spectra of 120-200 acquisitions were collected for use with the line fitting routine (described later) and to check the stability ofthe 31p spectrum.
Pacing protocol. Paced tachycardia allows rapid initiation and reversal ofthe change in cardiac work and its effects are largely limited to the heart as long as arterial blood pressure is maintained. Even if central compensatory responses tend to restore the control blood pressure, the rate pressure product and MVO2 remain elevated due to the tachycardia. In addition to being useful as a means of increasing cardiac work, paced tachycardia may be taken to a level that produces cardiac decompensation (14, 15) and/or supply/demand mismatching in both clinical and research settings, without producing irreversible myocardial damage. From preliminary observations it was decided to use paced changes in heart rate as a means of producing step increases and decreases in MVO2.
Cardiac pacing was synchronized to the respiratory cycle by driving the pacemaker from a PDP 1/23 computer (Digital Equipment Corp., Maynard, MA) at harmonics (accurate to < I ms) of the respiratory rate. The BASIC program for performing this task is available from the authors. Heart rate for the control periods was set at the lowest harmonic of the respiratory rate (i.e., -30 breaths/min), which exceeded the unpaced rate of the animal. A 120-200 acquisition (4-7 min) control spectrum was acquired, after which harmonic step increases of the heart rate were performed lasting -3 min with intervening -3-min returns to the control rate. Heart rate was increased in this manner until a rate was attained where the coronary sinus flow decreased (rather than increased) or pacing capture could no longer be maintained. In the five dogs without shunts heart rate was increased in the same manner until MAP decreased or capture could not be maintained. In the dogs with shunts, arterial and coronary sinus blood was sampled during each control and pace-up period and the oxygen content determined using a Lex-02-Con (Hospex, Chestnut Hill, MA). 31P NMR spectra were collected over 15-16-s blocks (eight acquisitions/ spectrum) continuously during the pacing protocol. After completing the sequence of pace-up and control periods, the heart rate was kept at the control rate while a postprotocol 120-200 acquisition spectrum was accumulated.
Data analysis. NMR FIDs were baseline corrected using the baseline correction routine resident in the GEMCSI software, zero-filled to 2 Kbytes and exponentially filtered to provide optimal line-broadening for phosphocreatine (PCr linewidth was between 7 and 15 Hz) before Fourier transformation. PCr/ATP for each spectrum was calculated as the ratio of the PCr and fl-ATP peak areas using a least-squares fitting routine written for the Nicolet 1280 computer in the CSI system (16) . Briefly, a high signal-to-noise reference spectrum was used as a model of the lineshape for each peak and fit on a least squares, point-by-point basis to the lower signal-to-noise data spectra. This method is more precise, at least as accurate, and requires far less time (-1 s to measure two peak windows in a 2-Kbyte spectrum) than conventional methods such as integration or Lorentzian/Gaussian fitting.
PCr/ATP ratios at the highest heart rate associated with an increase in hemodynamic parameters (coronary sinus flow and arterial blood pressure) were normalized to the control period (to compensate for variation between animals) and tested by one-way ANOVA for differences over the entire time course of each step-up and step-down in heart rate. If (17, 18) .
Mean arterial blood pressure (MAP) was calculated from the pressure waveform as diastolic + 1/3 pulse pressure and used to calculate the rate pressure product (RPP = heart rate X MAP). Left 
Results
Hemodynamic data. Hemodynamic parameters (heart rate, arterial blood pressure, RPP, CF) and MVO2 during the control periods (Tables I and II) Coronary sinus flow approximates left ventricular blood flow, but it is neither the only route for venous return from the left ventricle nor is its content exclusively comprised of left ventricular venous blood. For these reasons we consider the blood flow and MVO2 measured in these experiments estimates of those for the left ventricle. A major concern with this model was the possible influence of the shunt on the hemodynamics of the coronary sinus. This effect was studied in pre- liminary experiments using a shunt that contained a second, smaller lumen to directly monitor the coronary sinus pressure with the cannula in place. At basal rates ofcoronary sinus flow, the coronary sinus pressure remained below 4 mmHg throughout the cardiac cycle. At rates of flow exceeding those occurring in the protocol studies the diastolic coronary sinus pressure remained < 6 mmHg and systolic pressures reached a peak of 16 mmHg. This represents a worst case since, due to the second lumen, the diameter of the flow lumen of the twolumen shunt was 25% smaller than the cannula used during the protocol experiments. Coronary sinus pressure was not monitored during the protocol experiments so that the cannula lumen could be maximized, thus minimizing its resistance.
For reasons addressed in the Discussion, data for tachycardias associated with increased MVO2 were only included in this group if there was at least a 50% increase in MVO2 or, in the case of animals without shunts, a 50% increase in RPP. Five of the nine dogs with shunts (mean MVO2 increase 78%, range 64 to 1 12 per cent) and three of the five without shunts (mean RPP increase 82%, range 51 to 105%) met these criteria. Eight of the nine animals with shunts attained a level of tachycardia that produced a decrease in coronary sinus flow and five of the five animals without shunts reached a level of tachycardia causing MAP to decrease. To summarize, in the group of nine animals with a coronary sinus shunt: four dogs attained an increase in MVO2 > 50% at one heart rate and also reached a higher rate that produced a fall in coronary flow; four dogs did not have a paced heart rate which caused MVO2 to increase > 50% but did reach a rate that resulted in decreased coronary flow; 1 dog reached a heart rate that produced an increase in MVO2 > 50% but could not be paced to a rate causing coronary flow to decrease. Similarly, in the five dogs without shunts: three dogs attained heart rates at which RPP increased > 50% and also higher rates at which MAP decreased from the control level; two dogs did not have a paced harmonic heart rate which increased RPP by > 50% but could be paced to higher rates where MAP decreased from control levels.
Hemodynamic indices of the dogs that underwent the experimental protocol without the placement ofa coronary sinus shunt (Table II) were comparable during the control periods, as well as during the periods of increased heart rate, to dogs with coronary sinus shunts ( Table I ). The heart rates at which increases or decreases in hemodynamic parameters were ob- sents a real change, would affect PCr through the creatine kinase equilibrium (Eq. A2) < 5% in the opposite direction of the changes seen with pacing-induced decreases in coronary flow. The lack of change of intracellular pH during this brief stress is not surprising in view ofthe high buffer capacity ofthe myocardial cells (see reference 1 1) . The decrease of PCr/ATP was fully reversible within -1 min of resuming the control heart rate. Although there was a period of significant reactive hyperemia after this stress, there was no associated overshoot ofthe PCr/ATP ratio. MAP required -2 min to reach control levels following resumption of the control heart rate, as reflected by the significantly lower average MAP for the posttachycardia period (Table I) . Sample experimental records of hemodynamic changes, the associated PCr/ATP ratios and sample spectra from control, pace up and post-control periods for both levels of tachycardia are presented in Figs. 1 and 2 . Dogs without coronary sinus shunts had control PCr/ATP ratios (1.60±0.03), which did not statistically differ (P > 0.31) from those with shunts. In these animals tachycardias associated with increased blood pressure and RPP resulted in no change in PCr/ATP (P > 0.99). When the tachycardia in these dogs produced a significant decrease in the MAP and no change in the RPP the PCr/ATP ratio decreased significantly. These findings in dogs without shunts parallel those in dogs with shunts and demonstrate that the observed effects were independent of the cannulation of the coronary sinus.
Also important in demonstrating the validity of this model was' the occurrence of a decrease in the PCr/ATP ratio with tachycardia associated with a blunted hemodynamic and metabolic response. In addition to demonstrating that PCr/ATP decreases when the MVO2 fails to increase despite tachycardia, this finding establishes that the sensitivity and time resolution of the NMR measurements were adequate to detect the predicted (but not observed) decrease of PCr/ATP for levels of tachycardia associated with an increase in MVO2. This is par- ticularly important since the lack of statistical significance would be meaningless if using a measurement technique too insensitive to detect changes of the magnitude predicted. and PCr for the animals described in Table I We chose paced step changes between different heart rates to be the most rapid, reversible means of producing sudden which ultimately leads to a decline in hemodynamic performance (14). Furthermore, the NMR gating scheme used in this MINUTES study to minimize motion artifacts only allowed the heart rate re S. Simultaneous time courses of PCr/ATP, blood pressure to be incremented as integer multiples of the respiratory rate, myocardial flow during a paced increase and decrease in heart precluding the optimization of heart rate to maximize MVO2. Lssociated with a decrease in myocardial flow. (See Fig. 4 legFrom the results of previous work in this laboratory (6) it was All points represent data from eight dogs. (A) As in Fig. 4 are independent from each other (i.e., bireactant) (see Appendix), a 78% increase in myocardial MVO2 would result in a decrease in the PCr/ATP ratio from the control value of 1.55 to 1.24 if the ATP hydrolysis products were the sole mechanism responsible for metabolic feedback to the mitochondria. This did not occur, as can be clearly seen in Fig. 4 . A change of this magnitude would be statistically detectable by the methodology used in this study, as illustrated by the observation of a significant decrease in PCr/ATP among dogs paced to the point of hemodynamic compromise (Fig. 5) . Moreover, the bireactant model is a worst case scenario. Ifthe ATP hydrolysis products were not equally active in altering MVO2 the predicted change in PCr/ATP would be even greater. It is evident from Fig. 4 that the PCr/ATP ratio during tachycardias associated with increased hemodynamic indices did not change sufficiently to account for the observed increase of myocardial respiration, confirming previous results conducted under steady state conditions (6, 21) . The current study strengthens this premise, demonstrating that the lack of change ofthe PCr/ATP ratio is not simply due to a lack oftime resolution or failure to observe a transient change after an increase in cardiac work. The lack of significant change in PCr/ATP over the entire time course of a step-up/step-down in heart rate ( Fig. 4) also demonstrates that the metabolic feedback between the cytosolic use and mitochondrial production of ATP matches these two processes rapidly (i.e., within the 15-16-s time resolution of this study). If this were not the case the PCr/ATP ratio should have decreased during the initial stage of tachycardia (Fig. 4) until the production of ATP was increased to match the new demand. These observations support a mechanism of feedback for the regulation of myocardial respiration which is not primarily based on the concentrations of ADP and Pi. It should be noted that this differs from recent observations in the neonatal heart, where respiratory regulation may be very different than for adult animals (22) . Alternative hypotheses regarding the mechanisms ofmetabolic feedback to the mitochondria have been presented elsewhere (13, 23, 24) .
Although the high energy phosphates remained stable through the level of tachycardia illustrated in Fig. 4 , it was possible to cause changes in the PCr/ATP ratio by increasing heart rate to the point of hemodynamic compromise and decreased coronary blood flow (Fig. 5 ). Under these conditions of myocardial ischemia, as evidenced by the period of reactive hyperemia upon resuming the control heart rate, the decline of the PCr/ATP ratio and recovery upon resuming the control heart rate are well within the time resolution ofNMR spectroscopy. The time course of the fall in PCr/ATP when coronary flow (and presumably oxygen) was limiting is much more gradual than that predicted by an ADP, Pi bireactant model (Fig. 6 ).
Pacing-induced coronary ischemia is already a useful clinical tool (25). In combination with 31P NMR measurements, it offers the opportunity to characterize in vivo myocardial energy metabolism under normal and pathologic conditions. The ability to follow cardiac high energy phosphates over the time course ofa relatively briefmetabolic stress appears to be a sensitive indicator of coronary supply/demand imbalance and could provide useful information to both basic scientists and clinicians. Although the time resolution attained under the invasive conditions of this study is not presently available for cardiac NMR studies in humans, steady state 31P spectroscopy (i.e., several minutes acquisition time) are feasible (26) . The insight provided into myocardial biochemistry in vivo may also serve as a measure of coronary insufficiency during stress testing.
In summary, the results of this study demonstrate that previous 31p NMR findings during steady state conditions apply to the transient phase of changes in cardiac work. The left ventricular PCr/ATP ratio does not change sufficiently to explain tachycardia-induced increases in myocardial respiration, provided adequate myocardial blood flow can be maintained. When tachycardia resulted in a compromised coronary flow response the PCr/ATP ratio decreased significantly over -2 min until a new steady state was reached. This effect was fully reversible within 1 min of resuming the original heart rate.
These data indicate that: (a) transient changes in PCr/ATP do not occur following an increase in MVO2 provided the coronary blood flow is not compromised. Thus, when coronary flow can respond appropriately to a metabolic stress whatever feedback mechanism serves to link cytosolic ATP hydrolysis with mitochondrial oxidative phosphorylation in the heart does so rapidly; (b) factors other than the singular feedback of ATP hydrolysis products are involved in the regulation of myocardial respiration, and (c) during conditions where myocardial supply/demand mismatching occurs there is a rapid decrease in PCr/ATP, suggesting that the PCr/ATP ratio may be a useful marker of coronary ischemia in vivo.
Amol/g per min seen with tachycardia associated with increased coronary flow would account for an increase in ATP hydrolysis of 6 where the rate of (PCr formation) is determined from the rate of ATP formation via the creatine kinase equilibrium (MVO2i X 5.6 -ATP formation) and the rate of (PCr breakdown) makes a step increase at t = 0 determined from the rate of ATP hydrolysis (ATP hydrolysis final steady state MVO2 X 5.6). Eq. A5 can be solved for At by iteration, providing a time base for the previously determined values of MVO2 and [PCr] .
Using this model, the PCr/ATP ratio should decrease from the observed initial value of 1.55 to 1.24 (uncorrected for differential saturation) for the observed increase in MVO2 from 1.45 to 2.52 1mol/g per min (Table I ). The time course following the transient in cardiac work is plotted in Fig. 6 
